JMP Securities Reiterates Market Outperform on DBV Technologies, Maintains $4 Price Target
JMP Securities analyst Jonathan Wolleben reiterates DBV Technologies (NASDAQ:DBVT) with a Market Outperform and maintains $4 price target.
Earnings Scheduled For March 2, 2023
Companies Reporting Before The Bell
• argenx (NASDAQ:ARGX) is expected to report quarterly loss at $3.03 per share on revenue of $176.89 million.
12 Health Care Stocks Moving In Monday’s Intraday Session
Gainers Scopus BioPharma (NASDAQ:SCPS) stock rose 50.0% to $0.12 during Monday’s regular session. The current volume of 120.0K…
12 Health Care Stocks Moving In Monday’s Pre-Market Session
Gainers Immuron (NASDAQ:IMRN) stock rose 42.9% to $2.3 during Monday’s pre-market session. The market value of their outstanding…
Dow Rises 150 Points; Mission Produce Shares Slide
U.S. stocks traded mostly higher toward the end of trading, with the Dow Jones gaining around 150 points on Friday.
12 Health Care Stocks Moving In Friday’s Intraday Session
Gainers Immuron (NASDAQ:IMRN) shares increased by 37.9% to $2.22 during Friday’s regular session. As of 12:30 EST, this…
Dow Surges Over 100 Points; Crude Oil Rises Sharply
U.S. stocks traded mostly higher midway through trading, with the Dow Jones gaining over 100 points on Friday.
12 Health Care Stocks Moving In Friday’s Pre-Market Session
Gainers Immuron (NASDAQ:IMRN) stock increased by 42.2% to $2.29 during Friday’s pre-market session. The company’s market cap stands…
Why DBV Technologies Shares Are Trading Higher By 38%; Here Are 26 Stocks Moving Premarket
Gainers
Expion360 Inc. (NASDAQ: XPON) shares rose 152% to $2.47 in pre-market trading. Expion360 been selected as the exclusive supplier of high-energy lithium ion batteries for an overland trailer available through SUV dealerships nationwide.
DBV Technologies Shares Jumps As FDA Lifts Partial Hold On Pivotal Trial For Peanut Allergy Patch
The FDA has lifted the partial clinical hold on DBV Technologies (NASDAQ:DBVT) VITESSE Phase 3 clinical trial that will evaluate the modified…